FibroBiologics Q2 EPS $0.03 Beats $(0.09) Estimate; Cash $5.973M
FibroBiologics Q2 EPS $0.03 Beats $(0.09) Estimate; Cash $5.973M
FibroBiologics第二季度每股收益爲0.03美元，超過了-0.09美元的預期；現金爲597.3萬美元
FibroBiologics, Inc. - Common Stock (NASDAQ:FBLG) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.09) by 133.33 percent. This is a 137.5 percent increase over losses of $(0.08) per share from the same period last year.
Fibrobiologics, Inc.——普通股（納斯達克股票代碼：FBLG）公佈的季度收益爲每股0.03美元，比分析師普遍預期的0.09美元（0.09美元）高出133.33％。與去年同期每股虧損0.08美元（0.08）相比，增長了137.5％。